OBJECTIVES: The paper aims to identify the priorities for cardiovascular health promotion research in Central and Eastern Europe (CEE), the region with the highest cardiovascular diseases (CVD) burden in the world. METHODS: This narrative review covered peer-reviewed publications and online databases using a nonsystematic purposive approach. RESULTS: In despite of a steady decrease in CVD burden in the region, the East-West disparities are still significant. There is minimal continuity in the past and current CVD prevention efforts in the region. Many challenges still exist, including an opportunity gap in research funding, surveillance and population-based preventive interventions. A comprehensive approach focusing on multisectoral cooperation, quality and accessibility of healthcare and equity-oriented public policies and supported by well-designed epidemiologic studies is needed to overcome these challenges. CONCLUSION: The current level of effort is not adequate to address the magnitude of the CVD epidemic in CEE. It is imperative to strengthen the epidemiological base concerning cardiovascular health in the region, to foster surveillance and progress in implementation of CVD preventive strategies in the most affected populations of Europe.

Division of Preventive Cardiology Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota US

International Clinical Research Center St Anne's University Hospital Brno CR

Zobrazit více v PubMed

Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016; 37(42): 3232–3245. DOI: 10.1093/eurheartj/ehw334 PubMed DOI

Wilkins EWL, Wickramasinghe K, Bhatnagar P, et al. European Cardiovascular Disease Statistics 2017. European Heart Network Brussels; 2017

Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015; 132(17): 1667–1678. DOI: 10.1161/CIRCULATIONAHA.114.008720 PubMed DOI

Ezzati M, Obermeyer Z, Tzoulaki I, Mayosi BM, Elliott P, Leon DA. The contributions of risk factor trends and medical care to cardiovascular mortality trends. Nature reviews Cardiology. 2015; 12(9): 508–530. DOI: 10.1038/nrcardio.2015.82 PubMed DOI PMC

Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J. 2006; 27(1): 107–113. DOI: 10.1093/eurheartj/ehi511 PubMed DOI

Eurostat. Health in the European Union – facts and figures. Online publications 2017; http://ec.europa.eu/eurostat/statistics-explained/index.php/Health_in_the_European_Union_%E2%80%93_facts_and_figures. Accessed 26.02.2018.

Bobak M, Marmot M. East-West mortality divide and its potential explanations: proposed research agenda. BMJ. 1996; 312(7028): 421–425. DOI: 10.1136/bmj.312.7028.421 PubMed DOI PMC

Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000; 355(9205): 675–687. DOI: 10.1016/S0140-6736(99)11180-2 PubMed DOI

Hartley A, Marshall DC, Salciccioli JD, Sikkel MB, Maruthappu M, Shalhoub J. Trends in Mortality From Ischemic Heart Disease and Cerebrovascular Disease in Europe: 1980 to 2009. Circulation. 2016; 133(20): 1916–1926. DOI: 10.1161/CIRCULATIONAHA.115.018931 PubMed DOI

Unal B, Capewell S, Critchley JA. Coronary heart disease policy models: a systematic review. BMC Public Health. 2006; 6: 213 DOI: 10.1186/1471-2458-6-213 PubMed DOI PMC

Palmieri L, Bennett K, Giampaoli S, Capewell S. Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health. 2010; 100(4): 684–692. DOI: 10.2105/AJPH.2008.147173 PubMed DOI PMC

Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004; 109(9): 1101–1107. DOI: 10.1161/01.CIR.0000118498.35499.B2 PubMed DOI

Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005; 162(8): 764–773. DOI: 10.1093/aje/kwi274 PubMed DOI

Bruthans J, Cifkova R, Lanska V, et al. Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007. European journal of preventive cardiology. 2014; 21(7): 829–839. DOI: 10.1177/2047487312469476 PubMed DOI

Bandosz P, O’Flaherty M, Drygas W, et al. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: Modelling study. Bmj. 2012; 344: d8136 DOI: 10.1136/bmj.d8136 PubMed DOI PMC

Karanikolos M, Adany R, McKee M. The epidemiological transition in Eastern and Western Europe: a historic natural experiment. European Journal of Public Health. 2017; 27: 4–8. DOI: 10.1093/eurpub/ckx158 PubMed DOI

Murphy A, Johnson CO, Roth GA, et al. Ischaemic heart disease in the former Soviet Union 1990–2015 according to the Global Burden of Disease 2015 Study. Heart. 2018; 104(1): 58–66. DOI: 10.1136/heartjnl-2016-311142 PubMed DOI PMC

Puska P, Vartiainen E, Tuomilehto J, Salomaa V, Nissinen A. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases. Bull World Health Organ. 1998; 76(4): 419–425. PubMed PMC

Cobb FR, Kraus WE, Root M, Allen JD. Assessing risk for coronary heart disease: beyond Framingham. American Heart Journal.146(4): 572–580. DOI: 10.1016/S0002-8703(03)00500-3 PubMed DOI

Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European journal of preventive cardiology. 2016; 23(11): Np1–np96. PubMed

Bobak M, Malyutina S, Horvat P, et al. Alcohol, drinking pattern and all-cause, cardiovascular and alcohol-related mortality in Eastern Europe. Eur J Epidemiol. 2016; 31(1): 21–30. DOI: 10.1007/s10654-015-0092-8 PubMed DOI PMC

The Global Burden of Metabolic Risk Factors for Chronic Diseases C. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardio-metabolic risk factors between 1980 and 2010: Comparative risk assessment. The lancet Diabetes & endocrinology. 2014; 2(8): 634–647. DOI: 10.1016/S2213-8587(14)70102-0 PubMed DOI PMC

Stefler D, Bobak M. Does the consumption of fruits and vegetables differ between Eastern and Western European populations? Systematic review of cross-national studies. Archives of public health = Archives belges de sante publique. 2015; 73(1): 29–29. DOI: 10.1186/s13690-015-0078-8 PubMed DOI PMC

Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet. 2012; 380(9838): 247–257. DOI: 10.1016/S0140-6736(12)60646-1 PubMed DOI

Leon DA, Shkolnikov VM, McKee M, Kiryanov N, Andreev E. Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause? International Journal of Epidemiology. 2010; 39(5): 1279–1290. DOI: 10.1093/ije/dyq102 PubMed DOI PMC

Labarthe DR. From cardiovascular disease to cardiovascular health: a quiet revolution? Circulation Cardiovascular quality and outcomes. 2012; 5(6): e86–92. DOI: 10.1161/CIRCOUTCOMES.111.964726 PubMed DOI

Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010; 121(4): 586–613. DOI: 10.1161/CIRCULATIONAHA.109.192703 PubMed DOI

Lopez-Jimenez F. The Pursuit of Ideal Cardiovascular Health: An Individual and Societal Challenge. Mayo Clinic Proceedings. 2012; 87(10): 929–931. DOI: 10.1016/j.mayocp.2012.08.008 PubMed DOI PMC

Maclagan LC, Tu JV. Using the concept of ideal cardiovascular health to measure population health: a review. Curr Opin Cardiol. 2015; 30(5): 518–524. DOI: 10.1097/HCO.0000000000000210 PubMed DOI

Labarthe DR, Dunbar SB. Global cardiovascular health promotion and disease prevention: 2011 and beyond. Circulation. 2012; 125(21): 2667–2676. DOI: 10.1161/CIRCULATIONAHA.111.087726 PubMed DOI

Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed). 1981; 282(6279): 1847–1851. DOI: 10.1136/bmj.282.6279.1847 PubMed DOI PMC

Strasser T. Reflections on Cardiovascular Diseases. Interdisciplinary Science Reviews. 1978; 3(3): 225–230. DOI: 10.1179/030801878791925921 DOI

Mackenbach JP, Karanikolos M, McKee M. The unequal health of Europeans: successes and failures of policies. The Lancet. 381(9872): 1125–1134. DOI: 10.1016/S0140-6736(12)62082-0 PubMed DOI

Allen LN, Pullar J, Wickramasinghe K, et al. Are WHO “best buys” for non-communicable diseases effective in low-income and lower-middle-income countries? A systematic review. The Lancet Global Health. 2017; 5(Supplement 1): S17 DOI: 10.1016/S2214-109X(17)30124-9 PubMed DOI PMC

Gravely S, Giovino GA, Craig L, et al. Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. The Lancet Public Health. 2(4): e166–e174. DOI: 10.1016/S2468-2667(17)30045-2 PubMed DOI

Beaglehole R, Bonita R, Ezzati M, et al. NCD Countdown 2025: accountability for the the 25×25 NCD mortality reduction target. The Lancet. 384(9938): 105–107. DOI: 10.1016/S0140-6736(14)61091-6 PubMed DOI

Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2011(1): Cd001561 DOI: 10.1002/14651858.CD001561.pub3 PubMed DOI PMC

Merzel C, D’Afflitti J. Reconsidering community-based health promotion: promise, performance, and potential. Am J Public Health. 2003; 93(4): 557–574. DOI: 10.2105/AJPH.93.4.557 PubMed DOI PMC

Luepker RV. WHO MONICA project: what have we learned and where to go from here? Public Health Reviews. 2012(33): 373–396. DOI: 10.1007/BF03391642 DOI

World Health Organization (WHO). A strategy to prevent chronic disease in Europe. A focus on public health action: The CINDI vision. Copenhagen, Denmark; 2004.

Pearson TA, Palaniappan LP, Artinian NT, et al. American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: A scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation. 2013; 127(16): 1730–1753. DOI: 10.1161/CIR.0b013e31828f8a94 PubMed DOI

Evans A, Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K. Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol. 2001; 30: S35–40. DOI: 10.1093/ije/30.suppl_1.S35 PubMed DOI

Greer SL, Hervey TK, Mackenbach JP, McKee M. Health law and policy in the European Union. Lancet. 2013; 381(9872): 1135–1144. DOI: 10.1016/S0140-6736(12)62083-2 PubMed DOI

Rechel B, McKee M. Health reform in central and eastern Europe and the former Soviet Union. Lancet. 2009; 374(9696): 1186–1195. DOI: 10.1016/S0140-6736(09)61334-9 PubMed DOI

Adany RVA, Bislimovska J, Kulzhanov M. Public Health Education in Central and Eastern Europe, and Central Asia. Public Health Reviews. 2011(33): 105–133. DOI: 10.1007/BF03391623 DOI

Müller-Nordhorn J, Bjegovic-Mikanovic V, Otok R, Czabanowska K, Foldspang A. Fifty years of serving public health: the Association of Schools of Public Health in the European Region moving forward to the next half-century. International Journal of Public Health. 2016; 61(6): 631–632. DOI: 10.1007/s00038-016-0824-x PubMed DOI

Gilmore AB, McKee M. Tobacco and transition: an overview of industry investments, impact and influence in the former Soviet Union. Tobacco Control. 2004; 13(2): 136–142. DOI: 10.1136/tc.2002.002667 PubMed DOI PMC

Kontsevaya A, Sabgaida T, Ivanova A, Leon DA, McKee M. How has the management of acute coronary syndrome changed in the Russian Federation during the last 10 years? Health Policy. 121(12): 1274–1279. DOI: 10.1016/j.healthpol.2017.09.018 PubMed DOI PMC

Zatoński M, Zatoński WA, Przewoźniak K, Jaworski M. The significance and impact of the Polish Anti-tobacco Law. Journal of Health Inequalities. 2016; 2(1): 32–35. DOI: 10.5114/jhi.2016.61417 DOI

Boytsov SAORG, Maslennikova GY, Kalinina AM, Ipatov PV. Comprehensive Program for the Prevention of Non-communicable Diseases: Planning, Implementation and Evaluation. Journal of Preventive Medicine. 2012; 1.

Grigoriev P, Meslé F, Shkolnikov VM, et al. The Recent Mortality Decline in Russia: Beginning of the Cardiovascular Revolution? Population and Development Review. 2014; 40(1): 107–129. DOI: 10.1111/j.1728-4457.2014.00652.x DOI

Kilpelainen K, Tuomi-Nikula A, Thelen J, et al. Health indicators in Europe: availability and data needs. Eur J Public Health. 2012; 22(5): 716–721. DOI: 10.1093/eurpub/ckr195 PubMed DOI

European Society of Cardiology: Registries & Surveys. 2018; https://www.escardio.org/Research/Registries-&-surveys/Participate-in-a-registry. Accessed March 7, 2018.

Kotseva K, De Backer G, De Bacquer D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. European Journal of Preventive Cardiology. 2019; 26(8): 824–835. DOI: 10.1177/2047487318825350 PubMed DOI

Tillmann T, Pikhart H, Peasey A, et al. Psychosocial and socioeconomic determinants of cardiovascular mortality in Eastern Europe: A multicentre prospective cohort study. PLoS Medicine. 2017; 14(12): e1002459 DOI: 10.1371/journal.pmed.1002459 PubMed DOI PMC

Vandenheede H, Vikhireva O, Pikhart H, et al. Socioeconomic inequalities in all-cause mortality in the Czech Republic, Russia, Poland and Lithuania in the 2000s: Findings from the HAPIEE Study. Journal of Epidemiology and Community Health. 2014; 68(4): 297–303. DOI: 10.1136/jech-2013-203057 PubMed DOI PMC

Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low, middle, and high-income countries. Am Heart J. 2009; 158(1): 1–7.e1. DOI: 10.1016/j.ahj.2009.04.019 PubMed DOI

Dehghan M, Mente A, Zhang X, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): A prospective cohort study. The Lancet. 390(10107): 2050–2062. PubMed

Movsisyan NK, Vinciguerra M, Lopez-Jimenez F, et al. Kardiovize Brno 2030, a prospective cardiovascular health study in Central Europe: Methods, baseline findings and future directions. European journal of preventive cardiology. 2018; 25(1): 54–64. DOI: 10.1177/2047487317726623 PubMed DOI

Agodi A, Maugeri A, Kunzova S, et al. Association of Dietary Patterns with Metabolic Syndrome: Results from the Kardiovize Brno 2030 Study. Nutrients. 2018; 10(7). DOI: 10.3390/nu10070898 PubMed DOI PMC

Medina-Inojosa J, et al. Prevalence of Ideal Cardiovascular Health in a Central European Community: Results from Kardiovize Brno 2030 EuroPrevent 2018; 2018; Ljubjana, Slovenia: DOI: 10.1177/2047487319834875 PubMed DOI

Santoro A, Glonti K, Bertollini R, Ricciardi W, McKee M. Mapping health research capacity in 17 countries of the former Soviet Union and south-eastern Europe: An exploratory study. European Journal of Public Health. 2016; 26(2): 349–354. DOI: 10.1093/eurpub/ckv186 PubMed DOI

CORDIS EU Research Results Mapping. Chronic Non-Communicable Diseases Research Activities and their Impact: Final Report. http://cordis.europa.eu/result/rcn/184843_en.html European Commision, Community Research and Development Information Service (CORDIS); 2015.

McKee M, Haines A, Ebrahim S, et al. Towards a comprehensive global approach to prevention and control of NCDs. Globalization and health. 2014; 10: 74 DOI: 10.1186/s12992-014-0074-8 PubMed DOI PMC

Allebeck P. The prevention paradox or the inequality paradox? Eur J Public Health. 2008; 18(3): 215 DOI: 10.1093/eurpub/ckn048 PubMed DOI

Brennan P, Perola M, van Ommen GJ, Riboli E. Chronic disease research in Europe and the need for integrated population cohorts. Eur J Epidemiol. 2017; 32(9): 741–749. DOI: 10.1007/s10654-017-0315-2 PubMed DOI PMC

Histone H2A: a promising diagnostic marker in heart failure with reduced versus preserved ejection fraction

Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement

Can spirometry improve the performance of cardiovascular risk model in high-risk Eastern European countries?

Pharmacogenomic profile of a central European urban random population-Czech population

STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe

Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia, and associated risk factors in the Czech Republic, Russia, Poland and Lithuania: a cross-sectional study

Prediction of Cardiorespiratory Fitness in Czech Adults: Normative Values and Association with Cardiometabolic Health

Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health